PT Prodia Widyahusada Tbk (PRDA.JK)
IDR 2600.0
(-1.52%)
IDR 2600.0
(-1.52%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 259.87 Billion IDR | -30.08% |
| 2022 | 371.64 Billion IDR | -40.37% |
| 2021 | 623.23 Billion IDR | 131.9% |
| 2020 | 268.74 Billion IDR | 27.82% |
| 2019 | 210.26 Billion IDR | 19.84% |
| 2018 | 175.45 Billion IDR | 16.35% |
| 2017 | 150.79 Billion IDR | 71.1% |
| 2016 | 88.13 Billion IDR | 49.32% |
| 2015 | 59.02 Billion IDR | 0.79% |
| 2014 | 58.56 Billion IDR | -4.92% |
| 2013 | 61.59 Billion IDR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 39.04 Billion IDR | 60.21% |
| 2024 Q3 | 78.71 Billion IDR | 2.44% |
| 2024 Q2 | 76.62 Billion IDR | 96.23% |
| 2023 Q2 | 77.35 Billion IDR | 8.3% |
| 2023 Q1 | 71.42 Billion IDR | -25.94% |
| 2023 FY | 259.87 Billion IDR | -30.08% |
| 2023 Q4 | 24.37 Billion IDR | -71.9% |
| 2023 Q3 | 86.72 Billion IDR | 12.12% |
| 2022 Q2 | 54.56 Billion IDR | -48.14% |
| 2022 Q1 | 105.22 Billion IDR | -4.8% |
| 2022 FY | 371.64 Billion IDR | -40.37% |
| 2022 Q3 | 115.41 Billion IDR | 111.51% |
| 2022 Q4 | 96.44 Billion IDR | -16.44% |
| 2021 Q2 | 142.27 Billion IDR | -10.38% |
| 2021 Q3 | 210.06 Billion IDR | 47.65% |
| 2021 Q4 | 110.53 Billion IDR | -47.38% |
| 2021 FY | 623.23 Billion IDR | 131.9% |
| 2021 Q1 | 158.74 Billion IDR | 8.38% |
| 2020 Q4 | 146.46 Billion IDR | 9.0% |
| 2020 Q1 | 34.78 Billion IDR | -61.05% |
| 2020 Q2 | -46.87 Billion IDR | -234.78% |
| 2020 Q3 | 134.37 Billion IDR | 386.66% |
| 2020 FY | 268.74 Billion IDR | 27.82% |
| 2019 Q3 | 39.28 Billion IDR | 16.45% |
| 2019 Q4 | 89.29 Billion IDR | 127.31% |
| 2019 Q2 | 33.73 Billion IDR | -29.67% |
| 2019 Q1 | 47.95 Billion IDR | -30.45% |
| 2019 FY | 210.26 Billion IDR | 19.84% |
| 2018 Q4 | 68.95 Billion IDR | 51.1% |
| 2018 Q3 | 45.63 Billion IDR | 60.96% |
| 2018 Q2 | 28.35 Billion IDR | -12.78% |
| 2018 Q1 | 32.5 Billion IDR | -37.35% |
| 2018 FY | 175.45 Billion IDR | 16.35% |
| 2017 Q4 | 51.88 Billion IDR | 29.19% |
| 2017 FY | 150.79 Billion IDR | 71.1% |
| 2017 Q3 | 40.16 Billion IDR | 51.92% |
| 2017 Q2 | 26.43 Billion IDR | -18.18% |
| 2017 Q1 | 32.31 Billion IDR | -45.16% |
| 2016 Q1 | 24.15 Billion IDR | 79.73% |
| 2016 Q2 | 14.93 Billion IDR | -38.17% |
| 2016 Q3 | -9.87 Billion IDR | -166.11% |
| 2016 Q4 | 58.91 Billion IDR | 696.71% |
| 2016 FY | 88.13 Billion IDR | 49.32% |
| 2015 Q2 | 16.07 Billion IDR | 0.0% |
| 2015 Q4 | 13.44 Billion IDR | 0.0% |
| 2015 FY | 59.02 Billion IDR | 0.79% |
| 2015 Q1 | 16.07 Billion IDR | 0.0% |
| 2015 Q3 | 13.44 Billion IDR | -16.38% |
| 2014 FY | 58.56 Billion IDR | -4.92% |
| 2013 FY | 61.59 Billion IDR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| PT Diagnos Laboratorium Utama Tbk | -13.65 Billion IDR | 2003.029% |